Microgravity-enabled drug discovery
Feasibility pathways for protein crystallisation, disease models, molecular assembly and differentiated research environments.
Pharma
03 / Capability Fields
We bring together the scientific, engineering, operational and commercial capabilities required to explore where space environments can create measurable value on Earth.
Feasibility pathways for protein crystallisation, disease models, molecular assembly and differentiated research environments.
PharmaConcepts for compact biological systems, process monitoring, microfluidics, sensor integration and future orbital production.
BiotechCross-disciplinary collaboration around cell behaviour, mechanobiology, tissue structures and translation to terrestrial health.
Life ScienceRequirements definition, payload preparation, validation logic, operational planning and interfaces to platform providers.
Space OperationsProjects connecting microgravity, additive manufacturing, novel materials, precision systems and in-space manufacturing pathways.
IndustryDigital twins, experiment data layers, autonomous operations and AI-assisted research workflows for complex programmes.
Data · AI
04 / In-orbit operations
Every capability field is assessed against real platform constraints: mass, power, autonomy, crew time, sample integrity and the return journey.